Loading...

Forward Pharma A/S

FWP•NASDAQ
Healthcare
Biotechnology
$1.95
$0.00(0.00%)

Forward Pharma A/S (FWP) Stock Overview

Explore Forward Pharma A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 62.5/100

Key Financials

Market Cap0
P/E Ratio2118.18
EPS (TTM)N/A
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$1.14

FWP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Forward Pharma A/S (FWP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $1.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 2118.18 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for FWPStats details for FWP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for FWPAnalyst Recommendations details for FWP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

CEO

Claus Svendsen

Employees

4

Headquarters

Oestergade 24A, 1, Copenhagen K, Koebenhavn K

Founded

2014

Frequently Asked Questions

;